Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2013, Article ID 789413, 12 pages
http://dx.doi.org/10.1155/2013/789413
Research Article

Point-of-Care HIV Testing and Linkage in an Urban Cohort in the Southern US

1University of Alabama at Birmingham School of Medicine, Division of Infectious Diseases, 845 19th Street South, Bevill Biomedical Research Building 206B, Birmingham, AL 35294-2170, USA
2University of Alabama at Birmingham, School of Public Health, Department of Biostatistics, 1665 University Boulevard, RPHB 514-A, Birmingham, AL 35294, USA
3University of Alabama at Birmingham, School of Medicine, Division of Infectious Diseases, 908 20th Street South, CCB 188, Birmingham, AL 35294-2050, USA
4University of Alabama at Birmingham, School of Medicine, Division of Infectious Diseases, 908 20th Street South, CCB 245, Birmingham, AL 35294-2050, USA

Received 15 March 2013; Revised 14 June 2013; Accepted 23 July 2013

Academic Editor: Bryce D. Smith

Copyright © 2013 Anne Zinski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. CDC, HIV Counseling and Testing at CDC-Supported Sites—United States, 1999–2004, CDC, Atlanta, Ga, USA, 2006.
  2. CDC, Demonstration Projects for Health Departments and Community-Based Organizations (CBOs): Antiretroviral Treatment Access Study (ARTAS) II: Linkage to HIV Care, CDC, 2006.
  3. B. Branson, “Current HIV epidemiology and revised recommendations for HIV testing in health-care settings,” Journal of Medical Virology, vol. 79, supplement 1, pp. S6–S10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Wurcel, T. Zaman, S. Zhen, and D. Stone, “Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: a study of rapid versus standard testing,” AIDS Patient Care and STDs, vol. 19, no. 8, pp. 499–505, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. “Vital signs: HIV infection, testing, and risk behaviors among youths—United States,” Morbidity and Mortality Weekly Report, pp. 971–976, 2012.
  6. H. F. Raymond, T. Bingham, and W. McFarland, “Locating unrecognized HIV infections among men who have sex with men: San Francisco and Los Angeles,” AIDS Education and Prevention, vol. 20, no. 5, pp. 408–419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. P. Walensky, E. Losina, K. A. Steger-Craven, and K. A. Freedberg, “Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing,” Archives of Internal Medicine, vol. 162, no. 8, pp. 887–892, 2002. View at Google Scholar · View at Scopus
  8. M. L. Campsmith, P. H. Rhodes, I. Hall, and T. A. Green, “Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, pp. 619–624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Chen, P. H. Rhodes, I. H. Hall et al., “Prevalence of undiagnosed HIV infection among persons aged 13 years—National HIV Surveillance System, United States, 2005–2008,” Morbidity and Mortality Weekly Report, vol. 61, supplement, pp. 57–64, 2012. View at Google Scholar
  10. L. Peralta, B. G. Deeds, S. Hipszer, and K. Ghalib, “Barriers and facilitators to adolescent HIV testing,” AIDS Patient Care and STDs, vol. 21, no. 6, pp. 400–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Rizza, R. J. MacGowan, D. W. Purcell, B. M. Branson, and Z. Temesgen, “HIV screening in the health care setting: status, barriers, and potential solutions,” Mayo Clinic Proceedings, vol. 87, pp. 915–924, 2012. View at Google Scholar
  12. S. Schwarcz, T. A. Richards, H. Frank et al., “Identifying barriers to HIV testing: personal and contextual factors associated with late HIV testing,” AIDS Care, vol. 23, no. 7, pp. 892–900, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. N. P. Pai, C. Vadnais, C. Denkinger, N. Engel, and M. Pai, “Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries,” PLOS Medicine, vol. 9, Article ID e1001306, 2012. View at Google Scholar
  14. CDC, HIV Testing Trends in the United States, 2000-2011, CDC, Atlanta, Ga, USA, 2013.
  15. C. Hanssens, “Legal and ethical implications of opt-out HIV testing,” Clinical Infectious Diseases, vol. 45, supplement 4, pp. S232–S239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Bayer and G. M. Oppenheimer, “Routine HIV testing, public health, and the USPSTF—an end to the debate,” The New England Journal of Medicine, vol. 368, pp. 881–884, 2013. View at Google Scholar
  17. E. G. Martin and B. R. Schackman, “Updating the HIV-testing guidelines—a modest change with major consequences,” The New England Journal of Medicine, vol. 368, pp. 884–886, 2013. View at Google Scholar
  18. A. P. Mahajan, L. Stemple, M. F. Shapiro, J. B. King, and W. E. Cunningham, “Consistency of state statutes with the centers for disease control and prevention HIV testing recommendations for health care settings,” Annals of Internal Medicine, vol. 150, no. 4, pp. 263–269, 2009. View at Google Scholar · View at Scopus
  19. A. Qaseem, V. Snow, P. Shekelle, R. Hopkins Jr., and D. K. Owens, “Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association,” Annals of Internal Medicine, vol. 150, no. 2, pp. 125–131, 2009. View at Google Scholar · View at Scopus
  20. L. A. Kennedy, F. M. Gordin, and V. L. Kan, “Assessing targeted screening and low rates of HIV testing,” American Journal of Public Health, vol. 100, no. 9, pp. 1765–1768, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. S. Janssen, D. R. Holtgrave, R. O. Valdiserri, M. Shepherd, H. D. Gayle, and K. M. De Cock, “The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals,” American Journal of Public Health, vol. 91, no. 7, pp. 1019–1024, 2001. View at Google Scholar · View at Scopus
  22. OraSure Technologies, OraQuick ADVANCE Rapid HIV-1/2 Antibody Test. OraSure Technologies, OraSure Technologies, Bethlehem, Pa, USA, 2009.
  23. CDC, Quality Assurance Guidelines for Testing Using Rapid HIV Antibody Tests Waived Under the Clinical Laboratory Improvement Amendments of 1988, CDC, 2007.
  24. J. D. O'Neal, M. R. Golden, B. M. Branson, and J. D. Stekler, “HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men,” Journal of Acquired Immune Deficiency Syndromes, vol. 60, pp. e117–e120, 2012. View at Google Scholar
  25. Office of National AIDS Policy, National HIV/AIDS Strategy, The White House, Washington, DC, USA, 2010.
  26. S. D. Pinkerton and C. L. Galletly, “Reducing HIV transmission risk by increasing serostatus disclosure: a mathematical modeling analysis,” AIDS and Behavior, vol. 11, no. 5, pp. 698–705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. K. Sullivan, H. Curtis, C. A. Sabin, and M. A. Johnson, “Newly diagnosed HIV infections: review in UK and Ireland,” British Medical Journal, vol. 330, no. 7503, pp. 1301–1302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Marks, N. Crepaz, J. W. Senterfitt, and R. S. Janssen, “Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs,” Journal of Acquired Immune Deficiency Syndromes, vol. 39, no. 4, pp. 446–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. L. S. Weinhardt, “Effects of a detailed sexual behavior interview on perceived risk of HIV infection: preliminary experimental analysis in a high risk sample,” Journal of Behavioral Medicine, vol. 25, no. 2, pp. 195–203, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. R. P. Walensky, A. D. Paltiel, E. Losina et al., “Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC,” Clinical Infectious Diseases, vol. 51, pp. 392–400, 2010. View at Google Scholar
  31. R. P. Walensky and I. V. Bassett, “HIV self-testing and the missing linkage,” PLoS Medicine, vol. 8, no. 10, Article ID e1001101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Gopalappa, P. G. Farnham, A. B. Hutchinson, and S. L. Sansom, “Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons,” Journal of Acquired Immune Deficiency Syndromes, vol. 61, pp. 99–105, 2012. View at Google Scholar
  33. J. Bertolli, R. L. Shouse, L. Beer et al., “Using HIV surveillance data to monitor missed opportunities for linkage and engagement in HIV medical care,” The Open AIDS Journal, vol. 6, pp. 131–141, 2012. View at Google Scholar
  34. W. E. Norton, “An exploratory study to examine intentions to adopt an evidence-based HIV linkage-to-care intervention among state health department AIDS directors in the United States,” Implementation Science, vol. 7, article 27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Zinski, Who is in a hurry for HIV test results? An exploration of presentation for Oraquick rapid result HIV antibody testing in urban clinical and outreach settings in Alabama. Dissertation Abstracts International: Section B: The Sciences and Engineering, ProQuest International, 2008.
  36. K. Glanz, B. Rimer, and F. Lewis, Health Behavior and Health Education: Theory, Research, and Practice, Wiley & Sons, San Francisco, 2002.
  37. R. Wylie, M. Marler, H. Lin et al., “Project CONNECT: overcoming barriers to establishing HIV care,” in Proceedings of the 4th International Conference on HIV Treatment Adherence, Miami, Fla, USA, 2009,.
  38. D. S. Batey, S. T. Lawrence, N. C. Godwin et al., “Psychosocial symptom differences among new patient groups at an HIV medical clinic: project CONNECT,” in Society for Social Work and Research 14th Annual Conference, San Francisco, Ca, USA, 2010.
  39. Q. An, J. Prejean, and H. I. Hall, “Racial disparity in U.S. Diagnoses of acquired immune deficiency syndrome, 2000–2009,” American Journal of Preventive Medicine, vol. 43, pp. 461–466, 2012. View at Google Scholar
  40. T. A. Farley, “Sexually transmitted diseases in the Southeastern United States: location, race, and social context,” Sexually Transmitted Diseases, vol. 33, no. 7, pp. S58–S64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Fuqua, Y.-H. Chen, T. Packer et al., “Using social networks to reach Black MSM for HIV testing and linkage to care,” AIDS and Behavior, vol. 16, no. 2, pp. 256–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. N. T. Harawa, M. Leng, J. Kim, and W. E. Cunningham, “Racial/ethnic and gender differences among older adults in nonmonogamous partnerships, time spent single, and human immunodeficiency virus testing,” Sexually Transmitted Diseases, vol. 38, no. 12, pp. 1110–1117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. W. A. Hill and C. McNeely, “HIV/AIDS disparity between African-American and caucasian men who have sex with men: intervention strategies for the black church,” Journal of Religion and Health, vol. 52, no. 2, pp. 475–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. US Department of Commerce, “Jefferson County QuickFacts from the US Census Bureau,” in State and County QuickFacts. Data Derived From Population Estimates, American Community Survey, Census of Population and Housing, State and County Housing Unit Estimates, County Business Patterns, Nonemployer Statistics, Economic Census, Survey of Business Owners, Building Permits, Consolidated Federal Funds Report, US Census Bureau, 2013. View at Google Scholar
  45. N. Harawa and A. Adimora, “Incarceration, African Americans and HIV: advancing a research agenda,” Journal of the National Medical Association, vol. 100, no. 1, pp. 57–62, 2008. View at Google Scholar · View at Scopus
  46. D. Stratford, Y. Mizuno, K. Williams, C. Courtenay-Quirk, and A. O'Leary, “Addressing poverty as risk for disease: recommendations from CDC's consultation on microenterprise as HIV prevention,” Public Health Reports, vol. 123, no. 1, pp. 9–20, 2008. View at Google Scholar · View at Scopus
  47. M. Fisher, “Late diagnosis of HIV infection: major consequences and missed opportunities,” Current Opinion in Infectious Diseases, vol. 21, no. 1, pp. 1–3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Girardi, C. A. Sabin, and A. D. Monforte, “Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing,” Journal of Acquired Immune Deficiency Syndromes, vol. 46, supplement 1, pp. S3–S8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Schwarcz, L. Hsu, J. W. Dilley, L. Loeb, K. Nelson, and S. Boyd, “Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS,” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 4, pp. 491–494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. W. M. El-Sadr, T. R. Gamble, and M. S. Cohen, “Linkage from HIV testing to care: a positive test often leads nowhere,” Sexually Transmitted Diseases, vol. 40, pp. 26–27, 2013. View at Google Scholar
  51. S. S. Johnston, T. Juday, D. Seekins et al., “Patterns and correlates of linkage to appropriate HIV care after HIV diagnosis in the US Medicaid population,” Sexually Transmitted Diseases, vol. 40, pp. 18–25, 2013. View at Google Scholar
  52. N. M. Zetola, K. Bernstein, K. Ahrens et al., “Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007,” BMC Public Health, vol. 9, article 17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. N. P. Pai and M. Pai, “Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs,” Discovery Medicine, vol. 13, pp. 35–45, 2012. View at Google Scholar
  54. N. P. Pai, B. Balram, S. Shivkumar et al., “Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 12, no. 5, pp. 373–380, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Schito, T. F. Peter, S. Cavanaugh et al., “Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis,” Journal of Infectious Diseases, vol. 205, supplement 2, pp. S169–S180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. M. S. Cohen, Y. Q. Chen, M. McCauley et al., “Prevention of HIV-1 infection with early antiretroviral therapy,” The New England Journal of Medicine, vol. 365, pp. 493–505, 2011. View at Google Scholar
  57. J. A. Fleishman, B. R. Yehia, R. D. Moore, and K. A. Gebo, “The economic burden of late entry into medical care for patients with HIV infection,” Medical Care, vol. 48, no. 12, pp. 1071–1079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. C. S. Krawczyk, E. Funkhouser, J. M. Kilby, and S. H. Vermund, “Delayed access to HIV diagnosis and care: special concerns for the Southern United States,” AIDS Care, vol. 18, 1, pp. S35–S44, 2006. View at Publisher · View at Google Scholar · View at Scopus